Evidence map›Paper›PMID 39968946›Full record

ArticleeLife2025

AI-enabled alkaline-resistant evolution of protein to apply in mass production.

Liqi Kang, Banghao Wu, Bingxin Zhou, Pan Tan, Yun Kenneth Kang, Yongzhen Yan, Yi Zong, Shuang Li, Zhuo Liu, Liang Hong

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Protein foundation models: a comprehensive survey.Science China. Life sciences · 2026
    Review
  3. Review
  4. Recent Advances in Endolysin Engineering.Antibiotics (Basel, Switzerland) · 2025
    Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Liqi Kang *School of Physics and Astronomy, Shanghai Jiao Tong University, Shanghai, China.ORCID https://orcid.org/0009-0004-2427-5807
Banghao Wu *School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
Bingxin ZhouInstitute of Natural Sciences, Shanghai Jiao Tong University, Shanghai, China.ORCID https://orcid.org/0000-0002-3897-9766
Pan TanShanghai Artificial Intelligence Laboratory, Shanghai, China.
Yun Kenneth KangChangchun GeneScience Pharmaceuticals Co., Ltd., Jilin, China.
Yongzhen YanChangchun GeneScience Pharmaceuticals Co., Ltd., Jilin, China.
Yi ZongChangchun GeneScience Pharmaceuticals Co., Ltd., Jilin, China.
Shuang LiChangchun GeneScience Pharmaceuticals Co., Ltd., Jilin, China.
Zhuo LiuInstitute of Natural Sciences, Shanghai Jiao Tong University, Shanghai, China.ORCID https://orcid.org/0000-0001-9202-0516
Liang HongSchool of Physics and Astronomy, Shanghai Jiao Tong University, Shanghai, China.ORCID https://orcid.org/0000-0003-0107-336X

Funding

Computational Biology Program of Shanghai Science and Technology Commission 23JS1400600National Natural Science Foundation of China 12204302Natural Science Foundation of Shanghai 23ZR1431700Oceanic Interdisciplinary Program of Shanghai Jiao Tong University SL2022MS018Science and Technology Innovation Key R&D Program of Chongqing CSTB2022TIAD-STX0017Shanghai Jiao Tong University Scientific and Technological Innovation Funds 21X010200843Shanghai Pujiang Program 22PJ1406900Startup Fund for Young Faculty at SJTU SFYF at SJTU
6 · The paper itself

Abstract

Artificial intelligence (AI) models have been used to study the compositional regularities of proteins in nature, enabling it to assist in protein design to improve the efficiency of protein engineering and reduce manufacturing cost. However, in industrial settings, proteins are often required to work in extreme environments where they are relatively scarce or even non-existent in nature. Since such proteins are almost absent in the training datasets, it is uncertain whether AI model possesses the capability of evolving the protein to adapt extreme conditions. Antibodies are crucial components of affinity chromatography, and they are hoped to remain active at the extreme environments where most proteins cannot tolerate. In this study, we applied an advanced large language model (LLM), the Pro-PRIME model, to improve the alkali resistance of a representative antibody, a VHH antibody capable of binding to growth hormone. Through two rounds of design, we ensured that the selected mutant has enhanced functionality, including higher thermal stability, extreme pH resistance, and stronger affinity, thereby validating the generalized capability of the LLM in meeting specific demands. To the best of our knowledge, this is the first LLM-designed protein product, which is successfully applied in mass production.

Indexed as

AlkaliesArtificial IntelligenceProtein EngineeringHydrogen-Ion ConcentrationProtein StabilityAlkaliescomputational biologyE. coligrowth hormonenanobodyproteinsystems biology

Identifiers

PMID39968946
PMCPMC11839161

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.